See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2024_Y_mAbs_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001722964, Y mAbs Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,111,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,631,000 |
| 2 | PropertyPlantAndEquipmentNet | 224,000 |
| 3 | remainder_Assets | 13,903,000 |
| 4 | LiabilitiesCurrent | 20,128,000 |
| 5 | LiabilitiesNoncurrent | 1,381,000 |
| 6 | remainder_Liabilities | 5,375,000 |
| 7 | CostOfGoodsAndServicesSold | 30,607,707 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,513,052 |
| 9 | ResearchAndDevelopmentExpense | -8,550,392 |
| 10 | remainder_Expenses | 441,507 |
| 11 | remainder_Revenues | 146,067,797 |
| 12 | remainder_NetIncome | 2,706,516 |
| 13 | remainder_ComprehensiveNetIncome | -616,006 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 127,869,000 |
| 1 | Liabilities | 26,884,000 |
| 2 | Expenses | 46,011,874 |
| 3 | Revenues | 146,067,797 |
| 4 | StockholdersEquity | 100,985,000 |
| 5 | NetIncome | 102,762,439 |
| 6 | ComprehensiveNetIncome | 102,454,436 |
| 7 | BaseVar | 175,077,596 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.17 |
| 9 | EconomicCapitalRatio | 4.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
